Literature DB >> 21974776

Esthesioneuroblastoma chemotherapy and radiotherapy for extensive disease: a case report.

Seema Gupta1, Nuzhat Husain, Sham Sundar.   

Abstract

Malignant tumors of the nasal cavity are rare. We report the case of a 48 years old man who consulted us with a 2-year history of progressive nasal obstruction, occasional epistaxis, facial pain, and watering of the eyes. A diagnosis of olfactory neuroblastoma was established by histopathology and confirmed by immunohistochemistry. On staging, the mass was classified as a Kadish stage C tumor with extensive involvement of the nasal cavities, nasopharynx, paranasal sinuses and orbit. Endoscopic excision of the mass was done. Traditionally the mainstay of treatment in such locally advanced patients is craniofacial resection followed by adjuvant radiotherapy. Our patient was treated with limited surgery and chemoradiation. Patient is free of recurrence at a follow-up of 5 years. This case report demonstrates the potential efficacy of planned combined modality therapy, including limited surgery and early chemoradiation in the control of locally advanced olfactory neuroblastoma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21974776      PMCID: PMC3195723          DOI: 10.1186/1477-7819-9-118

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN: 1477-7819            Impact factor:   2.754


  5 in total

1.  Esthesioneuroblastoma: surgical treatment without radiation.

Authors:  H F Biller; W Lawson; V P Sachdev; P Som
Journal:  Laryngoscope       Date:  1990-11       Impact factor: 3.325

Review 2.  Esthesioneuroblastoma: a general review of the cases published since the discovery of the tumour in 1924.

Authors:  G Broich; A Pagliari; F Ottaviani
Journal:  Anticancer Res       Date:  1997 Jul-Aug       Impact factor: 2.480

3.  Cancer of the nasal cavity and paranasal sinuses: a series of 115 patients.

Authors:  V Svane-Knudsen; K E Jørgensen; O Hansen; A Lindgren; P Marker
Journal:  Rhinology       Date:  1998-03       Impact factor: 3.681

4.  Successful treatment of esthesioneuroblastoma and neuroendocrine carcinoma with combined chemotherapy and proton radiation. Results in 9 cases.

Authors:  N Bhattacharyya; A F Thornton; M P Joseph; M L Goodman; P C Amrein
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1997-01

Review 5.  Esthesioneuroblastoma: the role of adjuvant radiation therapy.

Authors:  R L Foote; A Morita; M J Ebersold; K D Olsen; J E Lewis; L M Quast; J A Ferguson; W M O'Fallon
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-11-15       Impact factor: 7.038

  5 in total
  1 in total

1.  Adrenocorticotropic Hormone-Dependent Cushing Syndrome Caused by an Olfactory Neuroblastoma.

Authors:  Cristina Familiar; Ane Azcutia
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2019-01-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.